Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: May 13, 2026

Transoral Robotic Total Thyroidectomy and Bilateral Central Regional Lymph Node Dissection for Papillary Thyroid Carcinoma
04:01

Transoral Robotic Total Thyroidectomy and Bilateral Central Regional Lymph Node Dissection for Papillary Thyroid Carcinoma

Published on: September 15, 2023

Rethinking prophylactic central neck dissection in clinically node-negative papillary thyroid cancer.

Dana M Hartl1, Martin Schlumberger2

  • 1Department of Surgery, Anesthesia and Interventional Radiology, Thyroid Surgery Unit, Gustave Roussy, Villejuif, France.

The Lancet. Diabetes & Endocrinology
|May 11, 2026
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Robot-assisted surgery for thyroid cancer].

Bulletin du cancer·2026
Same author

Post-Chornobyl thyroid papillary carcinomas display distinct past <sup>131</sup>I exposure and radiation-associated carcinogenesis molecular signatures at low and high thyroid doses.

Scientific reports·2026
Same author

Lesional dosimetry in <sup>131</sup>I refractory metastatic differentiated thyroid cancer with BRAFp.V600E or RAS mutation treated with trametinib +/- dabrafenib followed by radioactive iodine.

Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)·2026
Same author

Type 2 Deiodinase in Cancer-Associated Fibroblasts is Required to Sustain Growth of Poorly and Undifferentiated Thyroid Cancer.

Thyroid : official journal of the American Thyroid Association·2025
Same author

The rise of thyroid cancer incidence in adolescents and young adults.

The lancet. Diabetes & endocrinology·2025
Same author

Validation of the International Medullary Thyroid Carcinoma Grading System in Patients with Distant Metastases.

Thyroid : official journal of the American Thyroid Association·2025
Same journal

Endocrine-neuropsychological interplay underpinning maternal postpartum depression.

The lancet. Diabetes & endocrinology·2026
Same journal

Intermittent fasting to treat diabetes: time to update clinical practice guidelines.

The lancet. Diabetes & endocrinology·2026
Same journal

An important new data source for obesity trends in England.

The lancet. Diabetes & endocrinology·2026
Same journal

Whole-population trends in obesity across dimensions of inequality in England, 2019-25: a retrospective, longitudinal cohort study of 54 million adults.

The lancet. Diabetes & endocrinology·2026
Same journal

Diabetic foot ulcer prevention in Kuwait.

The lancet. Diabetes & endocrinology·2026
Same journal

High cost and poor availability of continuous glucose monitoring in low-income and middle-income countries.

The lancet. Diabetes & endocrinology·2026
See all related articles

Prophylactic central neck dissection for papillary thyroid cancer is controversial. While it may reduce recurrence, it doesn't improve survival and can increase complications, leaving decisions to clinicians.

Area of Science:

  • Oncology
  • Surgical Oncology
  • Head and Neck Surgery

Background:

  • Papillary thyroid cancer frequently presents with lymph node metastases, often in the central compartment.
  • These metastases are typically undetected preoperatively (cN0) and found during dissection.
  • The necessity of prophylactic central neck dissection (pCND) is debated due to low recurrence rates without it and potential morbidity.

Purpose of the Study:

  • To summarize the current evidence and controversy surrounding prophylactic central neck dissection in papillary thyroid cancer.
  • To explore the challenges in conducting randomized trials for surgical procedures like pCND.
  • To propose future research directions to resolve the ongoing debate.

Main Methods:

  • Review of existing clinical data and studies on prophylactic central neck dissection.

More Related Videos

"Sun's Seven-Step Technique" for Endoscopic En-Bloc Resection of Thyroid Cancer via the Chest-Breast Approach
07:45

"Sun's Seven-Step Technique" for Endoscopic En-Bloc Resection of Thyroid Cancer via the Chest-Breast Approach

Published on: November 28, 2025

Related Experiment Videos

Last Updated: May 13, 2026

Transoral Robotic Total Thyroidectomy and Bilateral Central Regional Lymph Node Dissection for Papillary Thyroid Carcinoma
04:01

Transoral Robotic Total Thyroidectomy and Bilateral Central Regional Lymph Node Dissection for Papillary Thyroid Carcinoma

Published on: September 15, 2023

"Sun's Seven-Step Technique" for Endoscopic En-Bloc Resection of Thyroid Cancer via the Chest-Breast Approach
07:45

"Sun's Seven-Step Technique" for Endoscopic En-Bloc Resection of Thyroid Cancer via the Chest-Breast Approach

Published on: November 28, 2025

  • Analysis of survival rates, regional recurrence rates, and associated morbidity (e.g., temporary hypoparathyroidism).
  • Discussion of current guideline recommendations and clinical decision-making processes.

    • Main Results:

    • Clinical data do not demonstrate a survival advantage with prophylactic central neck dissection.
    • Some studies suggest a reduction in regional recurrence rates but with an increase in morbidity.
    • Recurrence in clinically detected lymph nodes occurs in fewer than 10% of patients even without prophylactic dissection.

    Conclusions:

    • The decision for prophylactic central neck dissection remains complex and individualized.
    • Further research, potentially novel trial designs, is needed to definitively establish the role of pCND.
    • Balancing recurrence reduction against surgical morbidity is key in managing papillary thyroid cancer lymph node metastases.